Niraparib+Abiraterone bulk supplier for pharma manufacturers

Niraparib+Abiraterone 100mg+500mg / 200mg+1000mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 100mg+500mg / 200mg+1000mg

Reference Brands: AKEEGA (USA/EU)

Niraparib/Abiraterone is an oral dual-action anticancer therapy used for BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC). Niraparib is a PARP inhibitor that blocks DNA repair in cancer cells, leading to cell death, while Abiraterone acetate inhibits androgen biosynthesis, reducing tumor growth driven by male hormones. The combination is taken once daily with prednisone and is designed to improve treatment efficacy by targeting cancer through two complementary mechanisms. It is available as film-coated tablets in varying strengths.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Niraparib+Abiraterone — third party manufacturing & bulk supply

Niraparib+Abiraterone 100mg+500mg / 200mg+1000mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Niraparib+Abiraterone is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Niraparib+Abiraterone listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Niraparib+Abiraterone →

Back to Listing

Frequently Asked Questions

Niraparib+Abiraterone is listed as Tablet in 100mg+500mg / 200mg+1000mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Niraparib+Abiraterone is referenced against AKEEGA (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.